Evidence map›Paper›PMID 42186666›Full record

ArticleOrthopedic reviews2026

Management Patterns, Outcomes, and Timing Differences in Carpal Tunnel Syndrome Treatment: A Retrospective Review at a Single Institution from 2019-2024.

Christopher Eduard Lingat, Usama N Ismail, Gaurang M Amonkar, Derek S Anderson, Alexander Chueh, Sajan Goyal, Timothy T Huang, Justin Kim, Laya P Krishnan, Tyler B Nofzinger and 2 more

Abstract read
In one paragraph

Article in Orthopedic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Christopher Eduard LingatCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0005-1213-3876
Usama N IsmailCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0000-0001-5607-1463
Gaurang M AmonkarCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0000-0002-7238-7131
Derek S AndersonCarle Illinois College of Medicine University of Illinois Urbana-Champaign.
Alexander ChuehCarle Illinois College of Medicien University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0001-5164-0994
Sajan GoyalCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0002-7901-7114
Timothy T HuangCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0007-7880-3400
Justin KimCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0006-5440-7107
Laya P KrishnanCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0002-9851-911X
Tyler B NofzingerCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0009-0005-2319-528X
Royal ShresthaCarle Illinois College of Medicine University of Illinois Urbana-Champaign.ORCID https://orcid.org/0000-0003-0385-0919
Mark ShimaCarle Illinois College of Medicine University of Illinois Urbana-Champaign.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy that may be managed with conservative therapies and/or surgical decompression. Although both strategies are routinely used, limited data exists on how management patterns evolve within individual healthcare systems over time. This study examined trends in CTS treatment utilization, timing to surgery, and patient outcomes over a five-year period. Methods: A retrospective cohort study of adult patients diagnosed with CTS at the Carle Health System between September 1st, 2019 and September 1st, 2024 was conducted. Eligible records were identified through the electronic medical record and manually reviewed. Data collected included non-surgical and surgical treatments used, symptom improvement, follow-up completion, and timing intervals for injections and carpal tunnel release (CTR). Descriptive statistics were generated, and Fisher's exact and Kruskal-Wallis tests were used to explore annual differences. All inferential analysis were considered exploratory due to small sample size. Results: Of 516 identified patients, 62 met inclusion criteria. Across the study period, the proportion of patients receiving wrist splinting (43-73%) and CTR (43-73%) remained relatively stable, with CTR performed in 60% of patients overall. Management pathway distributions, non-surgical only (27%), surgical only (13%), both (47%), or no treatment (13%), did not differ significantly across years (p >0.05). Among patients receiving injections, 70% reported symptom improvement, while postoperative CTR cure rate was found to be 95%. CTR follow-up was completed in 73% of surgical patients. Median time from diagnosis to injection was 289 days, from diagnosis to CTR was 143 days, and from surgery to follow-up was 13 days, with no significant temporal differences (p>0.05). Conclusions: CTS management patterns at the Carle Health System have remained consistent from 2019-2024, with high rates of surgical success and variable time to intervention. Although sample size and documentation variability were limiting factors, these finding provide a baseline characterization of local practice and highlight opportunities to improve referral efficiency and postoperative follow-up. Larger studies are needed to better define the progression of CTS care trends.

Indexed as

Carpal Tunnel ReleaseCarpal Tunnel SyndromeHand Surgery

Identifiers

PMID42186666
PMCPMC13198905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.